These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2012627)

  • 21. Prostanoids and cyclosporin-mediated nephrotoxicity in rats: a critical appraisal.
    Casas A; Hotter G; Roselló-Catafau J; Fernández-Cruz L; Gelpí E
    Prostaglandins Leukot Essent Fatty Acids; 1995 Jan; 52(1):49-53. PubMed ID: 7708820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and molecular mechanisms of cyclosporin nephrotoxicity.
    Kopp JB; Klotman PE
    J Am Soc Nephrol; 1990 Aug; 1(2):162-79. PubMed ID: 2104260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of experimental cyclosporine nephrotoxicity by dietary supplementation with LSL 90202, a lysine salt of eicosapentaenoic acid. Role of thromboxane and prostacyclin in renal tissue.
    Torras J; Valles J; Sanchez J; Sabate I; Seron D; Carrera M; Castelao AM; Herrero I; Puig-Parellada P; Alsina J
    Nephron; 1994; 67(1):66-72. PubMed ID: 8052370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients.
    McNally PG; Walls J; Feehally J
    Nephrol Dial Transplant; 1990; 5(11):962-8. PubMed ID: 2127834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of eicosanoids in cyclosporine nephrotoxicity in the rat.
    Erman A; Chen-Gal B; Rosenfeld J
    Biochem Pharmacol; 1989 Jul; 38(13):2153-7. PubMed ID: 2735953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
    Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA
    J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis.
    Dijkmans BA; van Rijthoven AW; Goei The HS; Montnor-Beckers ZL; Jacobs PC; Cats A
    Eur J Clin Pharmacol; 1987; 31(5):541-5. PubMed ID: 3549319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritis.
    Dougados M; Duchesne L; Awada H; Amor B
    Ann Rheum Dis; 1989 Jul; 48(7):550-6. PubMed ID: 2673081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.
    Tugwell P; Ludwin D; Gent M; Roberts R; Bensen W; Grace E; Baker P
    J Rheumatol; 1997 Jun; 24(6):1122-5. PubMed ID: 9195520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A treatment of refractory rheumatoid arthritis.
    Weinblatt ME; Coblyn JS; Fraser PA; Anderson RJ; Spragg J; Trentham DE; Austen KF
    Arthritis Rheum; 1987 Jan; 30(1):11-7. PubMed ID: 3814192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cyclosporine on urinary kallikrein excretion in patients with rheumatoid arthritis.
    Spragg J; Weinblatt ME; Coblyn J; Fraser P; Austen KF
    J Lab Clin Med; 1988 Sep; 112(3):324-32. PubMed ID: 3411194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
    Yoo J; Schlondorff D; Neugarten J
    J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sulindac on renal and extrarenal eicosanoid synthesis.
    Cibattoni G; Boss AH; Patrignani P; Catella F; Simonetti BM; Pierucci A; Pugliese F; Filabozzi P; Patrono C
    Clin Pharmacol Ther; 1987 Apr; 41(4):380-3. PubMed ID: 3549118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients.
    Nawaz SH; Zafar MN; Naqvi SA; Rizvi SA
    J Pak Med Assoc; 2005 Mar; 55(3):98-100. PubMed ID: 15852743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
    Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
    Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fish oil and cyclosporin A-induced renal hypoperfusion in kidney-transplanted patients.
    Hansen JM; Høy CE; Strandgaard S
    Nephrol Dial Transplant; 1995; 10(9):1745-50. PubMed ID: 8559499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary modification of omega 6 fatty acid intake and its effect on urinary eicosanoid excretion.
    Blair IA; Prakash C; Phillips MA; Dougherty RM; Iacono JM
    Am J Clin Nutr; 1993 Feb; 57(2):154-60. PubMed ID: 8424383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
    Moutquin JM; Lindsay C; Arial N; De Grandpré P; C-Gaudreault R; Forest JC; Massé J
    Am J Obstet Gynecol; 1997 Dec; 177(6):1483-90. PubMed ID: 9423755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation.
    Textor SC; Wilson DJ; Lerman A; Romero JC; Burnett JC; Wiesner R; Dickson ER; Krom RA
    Transplantation; 1992 Jul; 54(1):74-80. PubMed ID: 1631948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.